trending Market Intelligence /marketintelligence/en/news-insights/trending/xyrmjABBWOABUuGEL1xyBg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Walgreens Q1'20 EPS, net income miss estimates

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Walgreens Q1'20 EPS, net income miss estimates

Walgreens Boots Alliance Inc. first-quarter adjusted EPS and net income fell short of estimates Jan. 8 as the pharmacy confirmed its 2020 guidance.

Adjusted diluted net EPS for the three months ended Nov. 30, 2019, of $1.37 missed the S&P Global Market Intelligence mean consensus estimate for normalized EPS of $1.41. Adjusted net earnings attributable to Walgreens Boots Alliance of $1.22 billion were lower than the Market Intelligence estimate of $1.25 billion for net income excluding exceptions.

Walgreens confirmed its previous 2020 guidance, saying that adjusted EPS growth would be "roughly flat" but could be higher or lower by 3%.

Sales for the quarter increased 2.3% on a constant-currency basis to $34.34 billion. Adjusted operating income declined 15.6%, or 15.4% in constant-currency terms, to $1.46 billion.

Shares of Walgreens Boots Alliance declined 4.1% to $56.87 in premarket trading Jan. 8. The retail pharmacy chain reported results before U.S. markets opened.